Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Busque, L
Right arrow Articles by Sokol, L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Busque, L
Right arrow Articles by Sokol, L
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Clonality in juvenile chronic myelogenous leukemia

L Busque, DG Gilliland, JT Prchal, CA Sieff, HJ Weinstein, JM Sokol, M Belickova, AS Wayne, KS Zuckerman and L Sokol

Division of Hematology-Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Juvenile chronic myelogenous leukemia (JCML) is a myeloproliferative disease in which morbidity and mortality are primarily caused by nonhematopoietic organ failure from myelomonocytic infiltration or by failure of the normal bone marrow. Morphologic evidence of maturation arrest, karyotypic abnormalities, and progression to blast crisis are infrequent events. Viral infections and other reactive processes can initially mimic the clinical course of JCML, creating diagnostic problems. Because of the rarity of JCML and technical limitations, formal clonality studies have not been reported previously. Nine female JCML patients were identified by clinical criteria, characteristic 'spontaneous' in vitro cell growth, and negative cultures and titers for various viral agents. Peripheral blood and bone marrow samples were obtained at the time of diagnosis for cell separation and RNA and DNA isolation. To assess clonality, X-chromosome inactivation patterns were evaluated using three different, recently developed polymerase chain reaction-based clonality assays. All nine female JCML patients showed evidence for monoclonal origin of mononuclear cells at the time of diagnosis. Cell separation studies further traced the monoclonal origin back to at least the most primitive myeloid progenitor cell. Reversion to a polyclonal state was demonstrated after bone marrow transplant and also in one patient following treatment with 13-cis retinoic acid. This demonstration of clonality in JCML delineates it from the reactive processes and provides a basis for molecular genetic strategies to identify causally associated mutations.

Volume 85, Issue 1, pp. 21-30, 01/01/1995
Copyright © 1995 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
haematolHome page
C. Flotho, C. P. Kratz, and C. M. Niemeyer
How a rare pediatric neoplasia can give important insights into biological concepts: a perspective on juvenile myelomonocytic leukemia
Haematologica, November 1, 2007; 92(11): 1441 - 1446.
[Full Text] [PDF]


Home page
ASH Education BookHome page
R. J. Arceci, B. J. Longley, and P. D. Emanuel
Atypical Cellular Disorders
Hematology, January 1, 2002; 2002(1): 297 - 314.
[Abstract] [Full Text]


Home page
BloodHome page
A. A. Axelrad, D. Eskinazi, P. N. Correa, and D. Amato
Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia
Blood, November 15, 2000; 96(10): 3310 - 3321.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. J. N. Cooper, K. M. Shannon, M. R. Loken, M. Weaver, K. Stephens, and E. L. Sievers
Evidence that juvenile myelomonocytic leukemia can arise from a pluripotential stem cell
Blood, September 15, 2000; 96(6): 2310 - 2313.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Mach-Pascual, R. D. Legare, D. Lu, M. Kroon, D. Neuberg, R. Tantravahi, R. M. Stone, A. S. Freedman, L. M. Nadler, J. G. Gribben, et al.
Predictive Value of Clonality Assays in Patients With Non-Hodgkin's Lymphoma Undergoing Autologous Bone Marrow Transplant: A Single Institution Study
Blood, June 15, 1998; 91(12): 4496 - 4503.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Pinkel;, M. Arico, A. Biondi, C.-H. Pui;, C.M. Niemeyer, S. Fenu, H. Hasle, G. Mann, J. Stary, and E. van Wering
Differentiating Juvenile Myelomonocytic Leukemia From Infectious Disease
Blood, January 1, 1998; 91(1): 365 - 367.
[Full Text] [PDF]


Home page
BloodHome page
M. Arico, A. Biondi, and C.-H. Pui
Juvenile Myelomonocytic Leukemia
Blood, July 15, 1997; 90(2): 479 - 488.
[Full Text] [PDF]


Home page
BloodHome page
C.M. Niemeyer, M. Arico, G. Basso, A. Biondi, A. C. Rajnoldi, U. Creutzig, O. Haas, J. Harbott, H. Hasle, G. Kerndrup, et al.
Chronic Myelomonocytic Leukemia in Childhood: A Retrospective Analysis of 110 Cases
Blood, May 15, 1997; 89(10): 3534 - 3543.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1995 by American Society of Hematology         Online ISSN: 1528-0020